ECMO and cytokine removal for bridging to surgery in a patient with ischemic ventricular septal defect - a case report

Research output: Journal article (peer-reviewed)Journal article

12 Citations (Scopus)

Abstract

Even in the modern era of percutaneous coronary intervention, postinfarction ventricular septal defect (VSD) remains a serious and often lethal complication. Whether or not immediate surgical repair or delaying surgery a few days aided by intra-aortic counterpulsation provides the optimal strategy remains a matter of debate. An interdisciplinary approach of intensivists and cardiac surgeons in this setting is mandatory. We report the use of veno-arterial extracorporeal membrane oxygenation and extracorporeal blood purification therapy (CytoSorb®) as bridging to surgical closure in a patient with an ischemic VSD leading to protracted cardiogenic shock after posterior myocardial infarction.

Original languageEnglish
Pages (from-to)526-529
Number of pages4
JournalInternational Journal of Artificial Organs
Volume40
Issue number9
DOIs
Publication statusPublished - 15 Sep 2017

Keywords

  • Cytokines/blood
  • Extracorporeal Membrane Oxygenation
  • Female
  • Hemodiafiltration
  • Humans
  • Male
  • Middle Aged
  • Shock, Cardiogenic/etiology
  • Systemic Inflammatory Response Syndrome/therapy
  • Ventricular Septal Rupture/therapy

Fingerprint

Dive into the research topics of 'ECMO and cytokine removal for bridging to surgery in a patient with ischemic ventricular septal defect - a case report'. Together they form a unique fingerprint.

Cite this